US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Noronex Limited (NRXO) 銘柄情報

Noronex Limited (NRXO)

0.001

0.00

(0.00%)

終了 7月13日 3:00PM

Noronex Limited (NRXO) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.001

出来高

0.00

平均取引量 (3 か月)

AUD 732,761

財務取引量

-

0.00 日の範囲 0.00

0.001 52 週間の範囲 0.006

時価総額

企業価値

5.905M

前日終値

0.001

始値

-

時刻

最終取引時間

VWAP

-

歳入

608.8k

純利益

-1.43M

発行済株式数

638,063,564

浮動株比率 (%)

50.04%

機関投資家保有比率 (%)

-

配当利回り

PER

-4.21

株価売上高倍率 (PSR)

11.53

1 株当たり利益 (EPS)

-0

ベータ

0.77

Noronex Limited engages in the mineral exploration in Australia, Namibia, and Canada. It primarily explores for uranium and copper deposits. The company’s flagship project is the Witvlei Copper project in Namibia. The company was formerly known as Lustrum Minerals Limited and changed its name to Nor... Noronex Limited engages in the mineral exploration in Australia, Namibia, and Canada. It primarily explores for uranium and copper deposits. The company’s flagship project is the Witvlei Copper project in Namibia. The company was formerly known as Lustrum Minerals Limited and changed its name to Noronex Limited in November 2020. Noronex Limited was incorporated in 2015 and is based in Subiaco, Australia. 詳細を表示

セクター

Materials

業界

Metals & Mining

ウェブサイト

noronexlimited.com.au

本社

Subiaco, Australia

設立

2026

Noronex Limited is listed in the Materials sector of the オーストラリア証券取引所 with ticker NRXO. The last closing price for Noronex was AUD0. Over the last year, Noronex shares have traded in a share price range of AUD 0.001 to AUD 0.006.

Noronex currently has 638,063,564 shares in issue. The market capitalisation of Noronex is AUD638,063.56 . Noronex has a price to earnings ratio (PE ratio) of -4.21.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0.001	0.001	0.001	350000	0.001	DE
12	0	0	0.001	0.001	0.001	350000	0.001	DE
26	-0.002	-66.6666666667	0.003	0.005	0.001	693742	0.00219122	DE
52	-0.003	-75	0.004	0.006	0.001	503633	0.00260344	DE
156	-0.003	-75	0.004	0.014	0.001	608746	0.00391095	DE
260	-0.003	-75	0.004	0.014	0.001	608746	0.00391095	DE

NRXO - Frequently Asked Questions (FAQ)

What is the current Noronex Limited share price?

The current share price of Noronex Limited is AUD 0.001

How many Noronex Limited shares are in issue?

Noronex Limited has 638,063,564 shares in issue

What is the market cap of Noronex Limited?

The market capitalisation of Noronex Limited is AUD 638.06k

What is the 1 year trading range for Noronex Limited share price?

Noronex Limited has traded in the range of AUD 0.001 to AUD 0.006 during the past year

What is the PE ratio of Noronex Limited?

The price to earnings ratio of Noronex Limited is -4.21

What is the cash to sales ratio of Noronex Limited?

The cash to sales ratio of Noronex Limited is 11.53

What is the registered address of Noronex Limited?

The registered address for Noronex Limited is 295 Rokeby Road, Subiaco, Western Australia, 6008

What is the Noronex Limited website address?

The website address for Noronex Limited is noronexlimited.com.au

Which industry sector does Noronex Limited operate in?

Noronex Limited operates in the Metals & Mining sector

Kjv

Absolutely. I just read through the PR again…they are already working. The tenses used in that PR..shows it.
On his personal MSK website, they are already selling MSK peptides for investigational purposes.
As soon as the approval mentioned in the PR solidifies…starting with PCAC review

ron_66271

ron_66271 7分前

$299 Billion is the FDIC Valuation for WMB Only.

Now multiply that by two for 41.6 “Willful Misconduct’ and then add the interest.
Using FJR of 1.95, actual interest rate may be greater.
I calculate that final payment for WMB is ~
$299*2=$

mikeo56

mikeo56 8分前

This could get interesting.

FDA-agent-2

FDA-agent-2 8分前

here is something the public don't understand about drugs
1. not everyone has the same side effect on the same drug
2. not everyone has th same blood type or biological makeup some people have natural immunity and some people have allergies.
if a drug has even 50% or 90% effect

mikeo56

mikeo56 9分前

NEWS
Release Date: 13/07/26 08:41
Summary: U.S. Government Backs Colosseum Operations
Price Sensitive: Yes
The announcement content will be available in 1 minutes at 09:01

skitahoe

skitahoe 10分前

In the past I was in a Pink that failed to report for years, then they did and the corporate shell was sold to a company in a business totally unrelated to what I invested in. I hope that won't be the case here.

Gary

GlitteringWanderer70

GlitteringWanderer70 13分前

Hey..I watched the Mets vs Red Sox game today and after Mets catcher took a foul ball off his shin guard he started limping around..I was pretty surprised when play by play announcer Gary Cohen started a conversation with Ron Darling..mentioned that sporting equipment companies really need to develo

mick

GetSeriousOK

GetSeriousOK 16分前

Friendly correction: that would be "wont," not "want."

For the next time you start wordsmithin'

Best of luck!

BIEL

mick

congrats to winner

FDA-agent-2

FDA-agent-2 16分前

And moderna vaccine in the fourth jab is obviously the culprit in the sudden death dyndrom of altelets as they are all on contracts and insured that were dropping like flies in 2021-2023 and forced to be vaccinated per their contact or too the fourth vaccine jab. now nbody takes the moderna 4 th dea

mick

congrats to winner

88TH MAN

88TH MAN 18分前

price_and_volume

price_and_volume 18分前

Lots of hopes & dreams posted on X...

Steffan isn't short on promises.

His followers aren't short on belief.

GLTA ~

GetSeriousOK

GetSeriousOK 18分前

The All Access Fund provides "up to $100,000." Electrome needs $$$ millions.

Hopefully, Electrome got more than $100,000 from angel investors referred to them by Capital Factory. I'm curious to know how those investors feel about Electrome after the bloody coup that sent Mayer packing

gemstone57

gemstone57 19分前

You can’t. Right now it’s an empty shell with ZERO revenues.

skitahoe

skitahoe 19分前

Doc, the beauty of NWBO is that it shouldn't cost that much to set up substantial production if you're using CDMO's and spoke activities that already have existing cleanroom and cryogenic capabilities. Certainly, they'll be paid for what they do, but all the company needs to do is supply them with

FDA-agent-2

FDA-agent-2 19分前

it's possible to survive any viral infection including AIDS with proper medication and early intervention. There is point where no drug can save a patient because they are beyond saving. the key is early intervention of virau infections that is was the case of humanigen some of the patients were too

Aquahoya

Aquahoya 19分前

I would like to believe if you are going to put that introductory PR out regarding the direction and pathways of the company, you do not have much further to wait to start seeing what has been going on behind the hood. I would expect some more updates, tweets, and PRs soon

1kgwxman

1kgwxman 21分前

The Texas Tech Provost has nothing to do with AMFN.

Dr. Ronald Hendrick serves as the Provost and Senior Vice President for Academic Affairs. In this role, he is the chief academic officer responsible for overseeing the university's academic mission, faculty success, and stude

price_and_volume

price_and_volume 21分前

From whom? Not how it works lol.
Yep they already got a verbal approval. No, they received "confirmation" of receipt of the request.

No reason for name-change to NOT be approved, but you constantly invent your own narrative.

Delaware SOS doesn't provide "verbal

FDA-agent-2

FDA-agent-2 23分前

You have to wonder why Shanjan Dr. is stil following a stock that has been delisted for over two years from the stock market.? he is either has a vested interest in the molecule Lenzi or/and works for Taran. Either way it doesn't matter.nobody would be wastin their time arguing whether a drug or mol

ipiros

ipiros 24分前

4 plus years for me also brother, hope you are wrong but might be right.

urge2surge

urge2surge 24分前

Past will be prologue. Expecting anything other than dilution and flip opportunities, especially given the evidences of negative roi, is discarding all past events and actions.
Takes two sides to make a market but it also takes a big step back to be objective. Could go either way here but r

US Market News

US Market News 26分前

KKR Leads A$400 Million Financing Solution for AmpolJuly 12, 2026 6:34 PM
Business Wire KKR, a leading global investment firm, today announced its cornerstone investment in a A$400 million (US$275 million) financing solution (the "Financing") for Ampol Limited (ASX: ALD) ("Ampo

DJ Real Estate Titans 30...

FTSEurofirst 300 Media

Source Energy Services

AES Brasil Energia ON

Atom Educacao E Editora ON

2.375% until 1apr2028

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。